Insider Transactions in Q3 2023 at Mi Nk Therapeutics, Inc. (INKT)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2023
|
Jennifer Buell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,000
-2.32%
|
$25,000
$1.15 P/Share
|
|
Sep 27
2023
|
Jennifer Buell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
695,750
+39.26%
|
-
|
|
Sep 01
2023
|
Ulf Wiinberg |
BUY
Grant, award, or other acquisition
|
Direct |
9,590
+13.76%
|
$9,590
$1.46 P/Share
|
|
Sep 01
2023
|
Barbara Ryan |
BUY
Grant, award, or other acquisition
|
Direct |
12,158
+19.29%
|
$12,158
$1.46 P/Share
|
|
Sep 01
2023
|
John Baldoni |
BUY
Grant, award, or other acquisition
|
Direct |
9,846
+19.29%
|
$9,846
$1.46 P/Share
|
|
Sep 01
2023
|
Brian Corvese |
BUY
Grant, award, or other acquisition
|
Direct |
12,244
+3.58%
|
$12,244
$1.46 P/Share
|
|
Sep 01
2023
|
Peter Behner |
BUY
Grant, award, or other acquisition
|
Direct |
10,531
+19.29%
|
$10,531
$1.46 P/Share
|
|
Aug 29
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
29,678
+0.14%
|
$29,678
$1.52 P/Share
|
|
Aug 28
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
12,808
+0.06%
|
$12,808
$1.45 P/Share
|
|
Aug 24
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
170,244
+0.78%
|
$170,244
$1.54 P/Share
|